Nitric oxide donors

Proceedings of the Society for Experimental Biology and Medicine

Volumn 225, Issue 3, 2000, Pages 200-206

  Yamamoto, T ^a   Bing, R J ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID 4 NITROXYBUTYL ESTER; GLYCERYL TRINITRATE; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; OXYGEN RADICAL; PROSTAGLANDIN SYNTHASE; PROSTANOID; SUPEROXIDE; THROMBOXANE B2;

ANGIOGENESIS; DRUG ACTIVITY; DRUG EFFECT; DRUG METABOLISM; DRUG STRUCTURE; HEART INFARCTION; NONHUMAN; PROSTAGLANDIN SYNTHESIS; SHORT SURVEY; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TUMOR VASCULARIZATION;

ANIMALS; ASPIRIN; DRUG TOLERANCE; HEART; HUMANS; MOLSIDOMINE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGLYCERIN; NITROPRUSSIDE; PLATELET AGGREGATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SUPEROXIDES; TRIAZENES;

EID: 0034521839     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22525.x     Document Type: Short Survey

References (97)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates
3. The effect of aspirin and two NO donors on the infarcted heart in situ
4. Nitric oxide-mediated cyclooxygenase activation: A key event in the antiplatelet effects of nitrovasodilators
5. Nitric oxide in the vasculature: Physiology and pathophysiology
6. Angiogenesis and the heart: Therapeutic implications
7. Free radical chemistry of nitric oxide: Looking at the dark side
8. 2 production in rats
9. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP
10. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells
11. Mechanisms of action of nitrates
12. Metabolism of nitroglycerin by smooth muscle cells: Involvement of glutathione and glutathione S-transferase
13. On the mechanism of NO release from sydnonimines
14. Clinical pharmacokinetics of molsidomine
15. Nitric oxide generation from nitroprusside by vascular tissue
16. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate
17. The nitrovasodilators: New ideas about old drugs
18. The relaxant properties in guinea pig airways of S-nitrosothiols
19. Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-alubumin and Snitroso-glutathione in human plasma
20. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats
21. The biochemical pathways of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions
22. "NONOates" (1-substituted Diazen-1-ium-1, 2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
23. Nitric oxide donors: A continuing opportunity in drug design
24. Nitric oxide-releasing aspirin derivative (NCX 4016): A gastric-sparing antithrombotic drug
25. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis and gastrointestinal damage induced by indomethacin in the rat
26. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
27. 2 production
28. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction
29. Role of nitric oxide in eicosanoide synthesis and uterine motility in estrogen-treated rat uteri
30. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
31. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro: Inhibition of 12-HPETE biosynthesis
32. Inhibition of coronary artery thrombosis by SIN a donor of nitric oxide
33. Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane after low-dose nitroglycerin
34. Comparative pharmacology of analogues of S-nitroso-Nacetyl-DL-penicillamine on human platelets
35. Antithrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative
36. 2 production
37. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
38. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction
39. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide if not a trigger of classical ischemic preconditioning
40. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
41. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart
42. Lactate accumulation in isolated hypoxic rat ventricular myocardium: Effect of different modulators of the cyclic GMP system
43. The effect of cyclic GMP on phosphofructokinase from rat tissues
44. A new method of measuring coronary blood flow in man
45. 84Rubidium
46. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside, and nitroglycerin
47. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols
48. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation
49. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A 375 melanoma cells via nitric oxide release
50. Nitric oxide (NO) donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro
51. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin
52. Inducible nitric oxide synthase activity in myocardium after myocardial infarction in rabbit
53. Myocardial infarction and nitric oxide
54. Macrophage cytotoxicity: Role for 1-arginine deiminase and imino nitrogen oxidation to nitrite
55. Dexamethasone on inducible nitric oxide synthase and nitrite/nitrate production in myocardial infarction
56. Effect of inhibitors of inducible form of nitric oxide synthase in infarcted heart muscle
57. Mechanism of tolerance development to organic nitrates
58. On-line measurement of nitric oxide release from organic nitrates in the intact coronary circulation. Nannyn-Schmiedeberg's
59. Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation
60. Nitroglycerin relaxes coronary artery of the pig with no change in glutathione content or glutathione-S-transferase activity
61. Desensitization to nitroglycerin in vascular smooth muscle from rat and human
62. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts
63. Mechanisms of nitrate tolerance
64. Evidence for enhanced vascular superoxide anion production in nitrate tolerance
65. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
66. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: A new action for an old drug
67. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist
68. 2-radical formation resulting from impaired NO-scavenging
69. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state. Naunyn-Schmiedeberg's
70. Suppression of nitrate-induced tolerance by vitamin C and other antioxidants
71. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure
72. Dietary supplement with vitamin C prevents nitrate tolerance
73. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance
74. Absence of nitrate tolerance after long-term treatment with ramipril: An endothelium-dependent mechanism
75. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance
76. Role of oxygen-derived metabolites in the rat gastric mucosal injury induced by nitric oxide donors
77. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
78. Peroxynitrite induces apoptosis in PC 12 cells and alters responses to neurotrophic factors
79. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart
80. Atherosclerosis and the two faces of endothelial nitric oxide synthase
81. -)). Atherosclerosis 147:
82. Monocytes and neutropbils oxidize low-density lipoprotein making it cytotoxic
83. Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite
84. Peroxynitrite formation from macrophage-derived nitric oxide
85. Extensive tyrosine nitration in human myocardial inflammation: Evidence for the presence of peroxynitrite
86. Mechanisms of angiogenesis and arteriogenesis
87. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
88. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
89. Role of nitric oxide in angiogenesis and microcirculation in tumors
90. Just say NO to cancer?
91. At the crossroads of inflammation and tumorigenesis
92. Role of nitric oxide in growth of solid tumors: A balancing act
93. Role of nitric oxide in pancreatic tumour growth: In vivo and in vitro studies
94. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
95. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium
96. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism
97. The pharmacology of a new nitric oxide donor: B-NOD